SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-18-044173
Filing Date
2018-07-06
Accepted
2018-07-06 17:00:33
Documents
1
Period of Report
2018-07-05

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 3051
  Complete submission text file 0001104659-18-044173.txt   4539
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3737 MARKET STREET, SUITE 1300 PHILADELPHIA PA 19104
Business Address
Furey John (Reporting) CIK: 0001691218 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37368 | Film No.: 18942937